Tag: Cannabis

Root Sciences Announces Partnership with Ecodyst

Root Sciences and Ecodyst have joined forces to provide hi-speed evaporators to the market for solvent recovery in cannabinoid applications. Solvent recovery is a common bottleneck in many cannabis processing operations. The unique line of products manufactured by Ecodyst provides single equipment solutions for solvent recovery, decarboxylation, and devolatilization to prepare crude oil for molecular

Link found between cannabis and rebound headaches after migraine

People with chronic migraines who use cannabis products are much more likely to suffer from “rebound headaches” than those who don’t use the drugs, a preliminary study suggests. However, though a link has been uncovered, it’s still unclear whether cannabis directly triggers the rebound headaches, the study authors told Live Science. The study also didn’t

The Potential Advantages of Patient-Directed Cannabis Therapy

The increased availability of cannabis throughout the United States, combined with the fact that approximately 115 Americans die every day as a result of opioid overdose, has pushed many individuals suffering from chronic pain to take it upon themselves to choose medical marijuana as a mid-level analgesic alternative. Image Credit: ElRoi / Shutterstock.com In addition

Give cannabis producers more packaging and labeling flexibility

While efforts to legalize recreational cannabis nationally have stalled in the United States, New Zealand, Mexico and Israel, Canada’s legal market continues to evolve. Health Canada has recently been receiving suggestions for revising its cannabis product regulations. Now it must decide what changes to make. One priority should be giving producers more packaging and labeling

Cannabis shows potential for mitigating sickle cell disease pain

Cannabis appears to be a safe and potentially effective treatment for the chronic pain that afflicts people with sickle cell disease, according to a new clinical trial co-led by University of California, Irvine researcher Kalpna Gupta and Dr. Donald Abrams of UC San Francisco. The findings appear in JAMA Network Open. “These trial results show

Hundreds are paying for private medical cannabis prescriptions

‘Hundreds’ of epilepsy and MS patients are paying up to £800 a month for private medicinal cannabis because ‘nothing has changed’ since health chiefs made them legal on the NHS Specialist doctors can prescribe unlicensed marijuana containing THC  There is thought to have been very few, if any, prescription on the NHS  NICE ruled cannabis

‘Cannabis addiction’ gene has been discovered by scientists

‘Cannabis addiction gene’ that could make people more likely to abuse the drug is discovered by scientists in a ‘really important’ breakthrough Gene CHRNA2 regulates a ‘nicotine receptor’ in the brain, scientists have said  Low levels of this receptor has been linked to an increased of marijuana abuse Discovery could help medics treat and even

Study points to increased risk of harm from cannabis across Europe

Cannabis resin and herbal cannabis have significantly increased in potency and in price, according to the first study to investigate changes in cannabis across Europe. The study, published today in the journal Addiction by researchers from the University of Bath and King’s College London, draws on data collected from across 28 EU Member states, as

First FDA-Approved Cannabis Drug Now Available in U.S.

THURSDAY, Nov. 1, 2018 — The first cannabis-based medication approved by the U.S. Food and Drug Administration is now available by prescription nationwide. Epidiolex is a twice-daily oral solution approved for use in patients age 2 years and older with two types of epileptic syndromes, Dravet syndrome and Lennox-Gastaut syndrome, CNN reported. The FDA approved

Teen cannabis use is not without risk to cognitive development

Although studies have shown that alcohol and cannabis misuse are related to impaired cognition in youth, previous studies were not designed to understand this relationship and differentiate whether cannabis use was causal or consequential to cognitive impairment. A new study by researchers at CHU Sainte-Justine and Université de Montréal, published in the American Journal of